These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1023 related articles for article (PubMed ID: 16697956)
1. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Certo M; Del Gaizo Moore V; Nishino M; Wei G; Korsmeyer S; Armstrong SA; Letai A Cancer Cell; 2006 May; 9(5):351-65. PubMed ID: 16697956 [TBL] [Abstract][Full Text] [Related]
2. Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. Aranovich A; Liu Q; Collins T; Geng F; Dixit S; Leber B; Andrews DW Mol Cell; 2012 Mar; 45(6):754-63. PubMed ID: 22464442 [TBL] [Abstract][Full Text] [Related]
4. B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins. Renault TT; Elkholi R; Bharti A; Chipuk JE J Biol Chem; 2014 Sep; 289(38):26481-26491. PubMed ID: 25096574 [TBL] [Abstract][Full Text] [Related]
5. Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET. Liu Q; Leber B; Andrews DW Cell Cycle; 2012 Oct; 11(19):3536-42. PubMed ID: 22895112 [TBL] [Abstract][Full Text] [Related]
6. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer. Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615 [TBL] [Abstract][Full Text] [Related]
7. BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia. Del Gaizo Moore V; Schlis KD; Sallan SE; Armstrong SA; Letai A Blood; 2008 Feb; 111(4):2300-9. PubMed ID: 18056841 [TBL] [Abstract][Full Text] [Related]
8. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Deng J; Carlson N; Takeyama K; Dal Cin P; Shipp M; Letai A Cancer Cell; 2007 Aug; 12(2):171-85. PubMed ID: 17692808 [TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Yecies D; Carlson NE; Deng J; Letai A Blood; 2010 Apr; 115(16):3304-13. PubMed ID: 20197552 [TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. Del Gaizo Moore V; Brown JR; Certo M; Love TM; Novina CD; Letai A J Clin Invest; 2007 Jan; 117(1):112-21. PubMed ID: 17200714 [TBL] [Abstract][Full Text] [Related]
11. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Rajan S; Choi M; Baek K; Yoon HS Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960 [TBL] [Abstract][Full Text] [Related]
12. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members. Santiveri CM; Sborgi L; de Alba E J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964 [TBL] [Abstract][Full Text] [Related]
13. Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA. Albershardt TC; Salerni BL; Soderquist RS; Bates DJ; Pletnev AA; Kisselev AF; Eastman A J Biol Chem; 2011 Jul; 286(28):24882-95. PubMed ID: 21628457 [TBL] [Abstract][Full Text] [Related]
14. BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes. Terrones O; Etxebarria A; Landajuela A; Landeta O; Antonsson B; Basañez G J Biol Chem; 2008 Mar; 283(12):7790-803. PubMed ID: 18195012 [TBL] [Abstract][Full Text] [Related]
15. Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinoma. Lheureux S; N'Diaye M; Blanc-Fournier C; Dugué AE; Clarisse B; Dutoit S; Giffard F; Abeilard E; Briand M; Labiche A; Grellard JM; Crouet H; Martin S; Joly F; Poulain L Int J Cancer; 2015 Mar; 136(5):E340-50. PubMed ID: 25066666 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999 [TBL] [Abstract][Full Text] [Related]
18. The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver. Kodama T; Hikita H; Kawaguchi T; Saito Y; Tanaka S; Shigekawa M; Shimizu S; Li W; Miyagi T; Kanto T; Hiramatsu N; Tatsumi T; Takehara T J Biol Chem; 2013 Oct; 288(42):30009-30018. PubMed ID: 23986435 [TBL] [Abstract][Full Text] [Related]
19. An interconnected hierarchical model of cell death regulation by the BCL-2 family. Chen HC; Kanai M; Inoue-Yamauchi A; Tu HC; Huang Y; Ren D; Kim H; Takeda S; Reyna DE; Chan PM; Ganesan YT; Liao CP; Gavathiotis E; Hsieh JJ; Cheng EH Nat Cell Biol; 2015 Oct; 17(10):1270-81. PubMed ID: 26344567 [TBL] [Abstract][Full Text] [Related]
20. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members. Hsu SY; Lin P; Hsueh AJ Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]